Cargando…
In vivo adaptive antimicrobial resistance in Klebsiella pneumoniae during antibiotic therapy
Klebsiella pneumoniae is one of the leading pathogens contributing to antimicrobial resistance. The emergence of carbapenem-resistant K. pneumoniae (CRKP) has put the use of clinical antimicrobial agents in a dilemma. In particular, CRKP exhibiting resistance to ceftazidime/avibactam, tigecycline an...
Autores principales: | Li, Shuangshuang, Feng, Xudong, Li, Min, Shen, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061107/ https://www.ncbi.nlm.nih.gov/pubmed/37007508 http://dx.doi.org/10.3389/fmicb.2023.1159912 |
Ejemplares similares
-
In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment
por: Chen, Jiawei, et al.
Publicado: (2021) -
Small Klebsiella pneumoniae Plasmids: Neglected Contributors to Antibiotic Resistance
por: Ramirez, Maria S., et al.
Publicado: (2019) -
CRISPR-Cas System in Antibiotic Resistance Plasmids in Klebsiella pneumoniae
por: Kamruzzaman, Muhammad, et al.
Publicado: (2020) -
Klebsiella pneumoniae: Development of Carbapenem Resistance due to Acquisition of bla(NDM-1) During Antimicrobial Therapy in Twin Infants with Pneumonia
por: Zhu, Junying, et al.
Publicado: (2015) -
Editorial: Klebsiella pneumoniae: Antimicrobial resistance, virulence and therapeutic strategies
por: Dong, Ning, et al.
Publicado: (2022)